Woodline Partners’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.7M Buy
+1,612,986
New +$37.3M 0.12% 221
2026
Q1
Sell
-462,390
Closed -$10.5M 1070
2025
Q4
$10.5M Sell
462,390
-3,207,113
-87% -$69.8M 0.04% 453
2025
Q3
$73.9M Buy
3,669,503
+480,318
+15% +$8.05M 0.35% 60
2025
Q2
$45.5M Buy
+3,189,185
New +$37.3M 0.24% 114
2024
Q3
Sell
-594,979
Closed -$8.59M 629
2024
Q2
$8.59M Buy
+594,979
New +$9.51M 0.08% 270
2024
Q1
Sell
-1,227,165
Closed -$18.3M 564
2023
Q4
$18.3M Sell
1,227,165
-2,612,962
-68% -$29.6M 0.2% 152
2023
Q3
$43.2M Buy
3,840,127
+3,130,273
+441% +$36.4M 0.51% 42
2023
Q2
$7.14M Buy
+709,854
New +$6.59M 0.08% 249
2021
Q3
Sell
-136,322
Closed -$4.73M 702
2021
Q2
$4.73M Buy
+136,322
New +$4.5M 0.09% 228
2021
Q1
Sell
-383,325
Closed -$11.8M 441
2020
Q4
$11.8M Buy
+383,325
New +$11.7M 0.31% 97

Other funds holding ELAN

Woodline Partners's ELAN Position: Q2 2026 in Review

Woodline Partners opened a new position in Elanco Animal Health (ELAN) in Q2 2026: 1,612,986 shares worth $39.7M. The stake represents 0.12% of the portfolio and ranks #221 among its holdings. This is a return to the name: Woodline Partners previously reported a position in ELAN as recently as Q4 2025.

Woodline Partners first reported a position in ELAN in Q4 2020 and has held it in 10 quarters since. The position peaked at $73.9M in Q3 2025. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Woodline Partners held 1,612,986 shares of Elanco Animal Health worth $39.7M as of Q2 2026.
  • Elanco Animal Health was a new Woodline Partners position in Q2 2026.
  • Elanco Animal Health made up 0.12% of Woodline Partners's portfolio in Q2 2026, its #221 holding.
  • Woodline Partners first reported a position in Elanco Animal Health in Q4 2020 and has held it in 10 quarters since.
  • Woodline Partners's Elanco Animal Health position peaked at $73.9M in Q3 2025.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.